ArticleDrug delivery and translational research2022
Regulatory safety evaluation of nanomedical products: key issues to refine.
Wim H De Jong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it